Theravance Bio Ord (TBPH)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2024 | 12-2023 | 12-2022 | 12-2021 | 12-2020 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 37,797 | 39,545 | 298,172 | 89,959 | 81,467 |
| Marketable Securities | 50,553 | 62,881 | 29,312 | 83,506 | 211,474 |
| Receivables | 68,440 | 17,474 | 16,785 | 14,065 | 15,868 |
| Other current assets | 73 | 2,038 | 1,513 | 53,779 | 74,173 |
| TOTAL | $161,067 | $133,541 | $353,464 | $249,870 | $393,341 |
| Non-Current Assets | |||||
| PPE Net | 7,418 | 9,068 | 11,875 | 13,657 | 16,422 |
| Investments And Advances | 0 | 0 | 0 | 67,537 | 12,750 |
| Other Non-Current Assets | 185,676 | 239,390 | 242,061 | 43,755 | 46,544 |
| TOTAL | $193,094 | $248,458 | $253,936 | $124,949 | $75,716 |
| Total Assets | $354,161 | $381,999 | $607,400 | $374,819 | $469,057 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | N/A | N/A | N/A | 16,940 | 19,334 |
| Accounts payable and accrued liabilities | 2,242 | 1,524 | 1,554 | 3,098 | 6,775 |
| Accrued Expenses | 10,006 | 9,343 | 14,334 | 19,634 | 45,260 |
| Other current liabilities | N/A | 6,490 | N/A | N/A | N/A |
| TOTAL | $32,085 | $24,767 | $28,715 | $58,587 | $123,571 |
| Non-Current Liabilities | |||||
| Long Term Debt | N/A | N/A | N/A | 371,359 | 372,873 |
| Deferred Revenues | N/A | N/A | N/A | 98 | 11,523 |
| Other Non-Current Liabilities | 146,531 | 144,237 | 136,693 | 283,136 | 276,016 |
| TOTAL | $146,531 | $144,237 | $136,885 | $654,805 | $649,237 |
| Total Liabilities | $178,616 | $169,004 | $165,600 | $713,392 | $772,808 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 49,471 | 48,165 | 62,864 | 74,697 | 64,328 |
| Common Shares | N/A | N/A | 1 | 1 | 1 |
| Retained earnings | -965,522 | -909,104 | -853,911 | -1,726,043 | -1,526,617 |
| Other shareholders' equity | 7 | -65 | -15 | 0 | 47 |
| TOTAL | $175,545 | $212,995 | $441,800 | $-338,573 | $-303,751 |
| Total Liabilities And Equity | $354,161 | $381,999 | $607,400 | $374,819 | $469,057 |